Company Overview and News

 
Global giant blasts 'ill-informed' criticism of pipeline deal

2018-09-30 theage.com.au
The company bidding $13 billion to buy Australian gas pipe network company APA Group has broken its silence, branding criticism of the deal on national security grounds "ill-informed" and "naive".
DUETF APA DUE

 
Global giant blasts 'ill-informed' criticism of pipeline deal

2018-09-30 watoday.com.au
The company bidding $13 billion to buy Australian gas pipe network company APA Group has broken its silence, branding criticism of the deal on national security grounds "ill-informed" and "naive".
DUETF APA DUE

 
Global giant blasts 'ill-informed' criticism of pipeline deal

2018-09-30 smh.com.au
The company bidding $13 billion to buy Australian gas pipe network company APA Group has broken its silence, branding criticism of the deal on national security grounds "ill-informed" and "naive".
DUETF APA DUE

 
Merger Arbitrage In One Place (Part 4) - Deals Of The East

2018-09-18 seekingalpha
This is the fourth and the last part of the currently followed deals, which contain situations of the Eastern part of our globe. Following posts are going to include news and updates on the deals + news deals and rumors whenever possible. For the first part and more details on the series please check here.
BGCHY CPQHF LUNMF BGA LUNCF CZZ DUETF LUN DUE

1
APA confident takeover suitor CKI will clear watchdog hurdles

2018-08-14 theage.com.au - 1
Gas pipeline company APA’s decision to back a takeover offer from Hong Kong-based CKI is not a done deal and needs to pass numerous watchdog hurdles before it gets the greenlight.
DUETF DUE

 
APA confident takeover suitor CKI will clear watchdog hurdles

2018-08-14 smh.com.au
Gas pipeline company APA’s decision to back a takeover offer from Hong Kong-based CKI is not a done deal and needs to pass numerous watchdog hurdles before it gets the greenlight.
DUETF DUE

 
APA backs CKI's $13b gas pipeline takeover

2018-08-12 theage.com.au
The board of Australian gas pipeline giant APA has unanimously backed Hong Kong-based utility firm CKI’s $13 billion takeover.
1038 HGKGF CKISY HGKGY CKISF DUETF DUE

 
APA backs CKI's $13b gas pipeline takeover

2018-08-12 smh.com.au
The board of Australian gas pipeline giant APA has unanimously backed Hong Kong-based utility firm CKI’s $13 billion takeover.
1038 HGKGF CKISY HGKGY CKISF DUETF DUE

 
Gorilla-wrestling over east coast gas to follow massive foreign bid

2018-07-01 theage.com.au
The Hong Kong bidder for Australian energy company APA’s gas pipelines may have to offload ownership of critical east coast gas pipelines in order to clinch regulator support for its $13 billion takeover.
530407 EPIC DUETF DUE

 
Gorilla-wrestling over east coast gas to follow massive foreign bid

2018-07-01 smh.com.au
The Hong Kong bidder for Australian energy company APA’s gas pipelines may have to offload ownership of critical east coast gas pipelines in order to clinch regulator support for its $13 billion takeover.
530407 EPIC DUETF DUE

 
Regulators still a hurdle CKI's $13b takeover bid for APA

2018-06-24 theage.com.au
Hong Kong-based infrastructure firm CKI has seen little resistance from the market and shareholders to its $13 billion takeover bid for gas pipeline group APA but there are still stumbling blocks ahead from government regulators.
DUETF DUE

 
Regulators still a hurdle CKI's $13b takeover bid for APA

2018-06-24 smh.com.au
Hong Kong-based infrastructure firm CKI has seen little resistance from the market and shareholders to its $13 billion takeover bid for gas pipeline group APA but there are still stumbling blocks ahead from government regulators.
DUETF DUE

19
APA's largest shareholder UniSuper open to joint takeover bid

2018-06-21 theage.com.au
APA’s largest shareholder UniSuper is open to a partnership with the Hong Kong group bidding $13 billion for the gas pipeline company, describing AustralianSuper's decision to team up with the failed private equity bid for hospital group Healthscope as "rational".
RTPPF RIO RIO TCL RIO RTNTF SYD DUETF TRAUF DUE SYDDF

19
APA's largest shareholder UniSuper open to joint takeover bid

2018-06-21 smh.com.au
APA’s largest shareholder UniSuper is open to a partnership with the Hong Kong group bidding $13 billion for the gas pipeline company, describing AustralianSuper's decision to team up with the failed private equity bid for hospital group Healthscope as "rational".
RTPPF RIO RIO TCL RIO RTNTF SYD DUETF TRAUF DUE SYDDF

 
Drummer and CEO Mick McCormack faces his toughest gig

2018-06-15 theage.com.au
When APA Group boss Michael McCormack retires he hopes to be able to pursue his love of drumming.
INCZY DUETF APA ICPVF IPL DUE

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to ASX:DUE / DUET GROUP on message board site Silicon Investor.

Delisting due to Sarbox cost of compliance Delisting due to Sarbox cost of compliance Delisting due to Sarbox cost of compliance Due Diligence - How to Investigate a Stock Due Diligence - How to Investigate a Stock Due Diligence - How to Investigate a Stock
DNAPrint (Due Diligence search) DNAPrint (Due Diligence search) DNAPrint (Due Diligence search) Under A Dollar With Earnings Due Out Within 30 Days Under A Dollar With Earnings Due Out Within 30 Days Under A Dollar With Earnings Due Out Within 30 Days
Durum Energy---V.DUE Durum Energy---V.DUE Durum Energy---V.DUE DD-CIA Due Diligence Central Intelligence Agency DD-CIA Due Diligence Central Intelligence Agency DD-CIA Due Diligence Central Intelligence Agency
DIME NEWS u0026 DD (Due Diligence) DIME NEWS u0026 DD (Due Diligence) DIME NEWS u0026 DD (Due Diligence)